Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Luigi Rossi,1,2 Enzo Veltri,3 Angelo Zullo,4 Federica Zoratto,1 Maria Colonna,5 Flavia Longo,6 Marcella Mottolese,7 Diana Giannarelli,8 Luigi Ruco,9 Paolo Marchetti,10 Adriana Romiti,10 Viola Barucca,10 Giuseppe Giannini,11 Loredana Bianchi,1 Silverio Tomao1 1Department of Medico-Surgical Sciences a...

Full description

Bibliographic Details
Main Authors: Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S
Format: Article
Language:English
Published: Dove Medical Press 2013-11-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/metastatic-colorectal-cancer-first-line-treatment-with-bevacizumab-the-a15130

Internet

http://www.dovepress.com/metastatic-colorectal-cancer-first-line-treatment-with-bevacizumab-the-a15130

Similar Items